speb/financial-data huggingface dataset:
Financial ratios for BLZ.AX — annual report dated 2023-06-30
Total revenue: 7849.0066225165565
Gross profit: 7849.0066225165565
Operating income: -712346.357615894
Net income: -706550.3311258279
Capital expenditures: 442754.9668874172
Depreciation & amortization: 9933.774834437087
Net tangible assets: 4398564.238410596
Owner earnings: -1139371.523178808
Return on net tangible assets (%): -25.903259823494484
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 2925000000
Book value: 4398564.238410597
P/B ratio: 8.807810857004512
Market cap (USD): 38741721.854304634
Debt to equity: 0
Current ratio: 9.464834408156314
Quick ratio: 9.464834408156314
COGS to revenue (%): 0
SG&A to revenue (%): 2362.470469119136
Free cash flow (dilution-adjusted): -930125.1655629139
Buyback yield (%): 0.019230769230769232
Retained earnings: -29707533.11258278
Receivables turnover: 0.5583981154299176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.19497451907847
FCF margin (%): -11850.227809652379
Revenue growth (%): 93.85214789046171
Rule of 40 score: -11756.375661761916
Financial ratios for BMRN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 88.35
Shares outstanding: 193284438
Market cap (USD): 17076680097.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMRN — annual report dated 2022-12-31
Total revenue: 2096039000
Gross profit: 1593016000
Operating income: 57410000
Net income: 141561000
Capital expenditures: 120959000
Operating cash flow: 175902000
Depreciation & amortization: 101969000
Net tangible assets: 4068388000
Owner earnings: 122571000
Return on net tangible assets (%): 3.0127657440735742
Capex to operating income (%): 210.69325901410903
Buffett classification: The Gruesome
Stock price: 103.49
P/E ratio: 141.3030883408566
Shares outstanding: 193284438
Book value: 4603156000
P/B ratio: 4.345498281748435
Market cap (USD): 20003006488.62
Debt to equity: 0.23753138064406246
Current ratio: 4.672324260805184
Quick ratio: 3.1540575053830637
Effective tax rate (%): 5.358479970048671
Interest coverage ratio: 4.155928767916606
COGS to revenue (%): 23.998742389812403
R&D to revenue (%): 30.99207600621935
SG&A to revenue (%): 39.27407839262533
Free cash flow (dilution-adjusted): -151946000
Buyback yield (%): 0
Retained earnings: -789199000
Inventory turnover: 0.5626133144238287
Receivables turnover: 4.543607852318151
Capitalized R&D asset: 649606000
ROCI (R&D-adjusted, %): 7.621134458995696
FCF margin (%): -7.249197176197581
Rule of 40 score: -7.249197176197581
Financial ratios for BMRN — annual report dated 2023-12-31
Total revenue: 2419226000
Gross profit: 1887164000
Operating income: 185780000
Net income: 167645000
Capital expenditures: 96691000
Operating cash flow: 159259000
Depreciation & amortization: 104386000
Net tangible assets: 4460649000
Owner earnings: 175340000
Return on net tangible assets (%): 3.9308181387954977
Capex to operating income (%): 52.04596834966089
Buffett classification: The Good
Stock price: 96.42
P/E ratio: 111.16636650040265
Shares outstanding: 193284438
Book value: 4951549000
P/B ratio: 3.7637687745713513
Market cap (USD): 18636485511.96
Debt to equity: 0.2212945888246284
Current ratio: 2.511493393507694
Quick ratio: 1.5708303314121037
Effective tax rate (%): 11.093374628108378
Interest coverage ratio: 10.717046437842516
COGS to revenue (%): 21.993067204138843
R&D to revenue (%): 30.868261171134897
SG&A to revenue (%): 36.8878310666304
Free cash flow (dilution-adjusted): -155451000
Buyback yield (%): 0
Retained earnings: -621554000
Inventory turnover: 0.48055470504875886
Receivables turnover: 3.8175962278918862
Capitalized R&D asset: 1182009020
ROCI (R&D-adjusted, %): 6.822278950754413
Rosenberg metric: 0.4528098570518129
FCF margin (%): -6.425650187291307
Revenue growth (%): 15.418940201017254
Rule of 40 score: 8.993290013725947
Financial ratios for BMRN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 70.29
Shares outstanding: 193284438
Market cap (USD): 13585963147.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMRN — annual report dated 2024-12-31
Total revenue: 2853915000
Gross profit: 2273680000
Operating income: 474239000
Net income: 426859000
Capital expenditures: 85424000
Operating cash flow: 572841000
Depreciation & amortization: 96426000
Net tangible assets: 5206513000
Owner earnings: 437861000
Return on net tangible assets (%): 8.409870483373421
Capex to operating income (%): 18.0128584954
Buffett classification: The Great
Stock price: 65.73
P/E ratio: 29.76295711169262
Shares outstanding: 193284438
Book value: 5657990000
P/B ratio: 2.2454239243512273
Market cap (USD): 12704586109.740002
Debt to equity: 0.10652404829276828
Current ratio: 5.325355690722057
Quick ratio: 3.2945857249237216
Effective tax rate (%): 21.209274166009862
Interest coverage ratio: 37.44189167850939
COGS to revenue (%): 20.331194166609727
R&D to revenue (%): 26.18101800509125
SG&A to revenue (%): 35.354942246002416
Free cash flow (dilution-adjusted): 273852000
Buyback yield (%): 0
Retained earnings: -194695000
Inventory turnover: 0.47072047040002335
Receivables turnover: 4.320611322639981
Capitalized R&D asset: 1461891890
ROCI (R&D-adjusted, %): 6.462418262125816
Rosenberg metric: 0.5175816479706684
FCF margin (%): 9.595660697673196
Revenue growth (%): 17.968102194668873
Rule of 40 score: 27.56376289234207
Financial ratios for BMRN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 65.73
Shares outstanding: 193284438
Market cap (USD): 12704586109.740002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMRN — quarterly report dated 2025-03-31
Total revenue: 745145000
Gross profit: 593587000
Operating income: 223909000
Net income: 185686000
Capital expenditures: 16768000
Operating cash flow: 174394000
Depreciation & amortization: 22069000
Net tangible assets: 5349914000
Owner earnings: 190987000
Return on net tangible assets (%): 3.569907852724362
Capex to operating income (%): 7.4887565930802245
Buffett classification: The Great
Stock price: 70.69
P/E ratio: 18.395674582655666
Shares outstanding: 193284438
Book value: 5793459000
P/B ratio: 2.358397103046729
Market cap (USD): 13663276922.22
Debt to equity: 0.10390321222606391
Current ratio: 5.5202693990732445
Quick ratio: 3.490944950200012
Effective tax rate (%): 22.009836657720435
Interest coverage ratio: 78.20782396088019
COGS to revenue (%): 20.339397030108234
R&D to revenue (%): 21.302028464258633
SG&A to revenue (%): 27.65904622590234
Free cash flow (dilution-adjusted): 119926000
Buyback yield (%): 0
Retained earnings: -9009000
Inventory turnover: 0.11888319234920555
Receivables turnover: 1.0080738442889863
Capitalized R&D asset: 158731000
ROCI (R&D-adjusted, %): 4.937902391479877
FCF margin (%): 16.09431721342826
Rule of 40 score: 16.09431721342826
Financial ratios for BMRN — quarterly report dated 2025-06-30
Total revenue: 825410000
Gross profit: 675320000
Operating income: 276866000
Net income: 240532000
Capital expenditures: 17101000
Operating cash flow: 185271000
Depreciation & amortization: 18563000
Net tangible assets: 5591294000
Owner earnings: 241994000
Return on net tangible assets (%): 4.328050000590204
Capex to operating income (%): 6.176634184045712
Buffett classification: The Great
Stock price: 54.97
P/E ratio: 24.928195329291587
Shares outstanding: 193284438
Book value: 6027113000
P/B ratio: 1.7628416054021219
Market cap (USD): 10624845556.86
Debt to equity: 0.1001915842626478
Current ratio: 5.561342614582161
Quick ratio: 3.602738484786926
Effective tax rate (%): 19.248794768152337
Interest coverage ratio: 103.34677118327734
COGS to revenue (%): 18.183690529555008
R&D to revenue (%): 19.542772682666794
SG&A to revenue (%): 28.143589246556257
Free cash flow (dilution-adjusted): 120373000
Buyback yield (%): 0
Retained earnings: 231523000
Inventory turnover: 0.11199333815362092
Receivables turnover: 0.964427385480017
Capitalized R&D asset: 267657770
ROCI (R&D-adjusted, %): 4.708892361034675
Rosenberg metric: 0.5149151709495939
FCF margin (%): 14.58341914927127
Revenue growth (%): 10.771728992343773
Rule of 40 score: 25.355148141615043
Financial ratios for BMRN — quarterly report dated 2025-09-30
Total revenue: 776133000
Gross profit: 636048000
Operating income: -46677000
Net income: -30744000
Capital expenditures: 28447000
Operating cash flow: 368685000
Depreciation & amortization: 18487000
Net tangible assets: 5627400000
Owner earnings: -40704000
Return on net tangible assets (%): -0.7233180509649216
Buffett classification: The Gruesome
Stock price: 54.16
P/E ratio: 26.47022348392056
Shares outstanding: 193284438
Book value: 6056711000
P/B ratio: 1.7283778542644677
Market cap (USD): 10468285162.08
Debt to equity: 0.09976388175034272
Current ratio: 4.827604648075367
Quick ratio: 3.096508432714876
Interest coverage ratio: -18.098875533152384
COGS to revenue (%): 18.049097255238472
R&D to revenue (%): 52.7587410920551
SG&A to revenue (%): 34.58170184749264
Free cash flow (dilution-adjusted): 285670000
Buyback yield (%): 0
Retained earnings: 200779000
Inventory turnover: 0.10135127802380745
Receivables turnover: 0.9821161482336327
Capitalized R&D asset: 569935590
ROCI (R&D-adjusted, %): 1.619587674195621
Rosenberg metric: -0.24345971681503706
FCF margin (%): 36.80683594177802
Revenue growth (%): -5.970002786493985
Rule of 40 score: 30.836833155284033
Financial ratios for BMRN — annual report dated 2025-12-31
Total revenue: 3221253000
Gross profit: 2503811000
Operating income: 409495000
Net income: 348901000
Capital expenditures: 103038000
Operating cash flow: 827994000
Depreciation & amortization: 79557000
Net tangible assets: 5676963000
Owner earnings: 325420000
Return on net tangible assets (%): 5.732290310858112
Capex to operating income (%): 25.162211992820428
Buffett classification: The Good
Stock price: 59.43
P/E ratio: 32.923076031137775
Shares outstanding: 193284438
Book value: 6086999000
P/B ratio: 1.8871194410151866
Market cap (USD): 11486894150.34
Debt to equity: 0.09953361254043248
Current ratio: 5.2086014932196445
Quick ratio: 3.4973630853021813
Effective tax rate (%): 27.685914442049413
Interest coverage ratio: 37.57179557757593
COGS to revenue (%): 22.272140685627612
R&D to revenue (%): 28.620229457295032
SG&A to revenue (%): 35.793525066177665
Free cash flow (dilution-adjusted): 535610000
Buyback yield (%): 0
Retained earnings: 154206000
Inventory turnover: 0.5523530602833358
Receivables turnover: 3.5467995428390227
Capitalized R&D asset: 1668978370
ROCI (R&D-adjusted, %): 6.186867690156478
Rosenberg metric: 0.3079977622647166
FCF margin (%): 16.627380711791343
Revenue growth (%): 12.871371431875161
Rule of 40 score: 29.498752143666504
Financial ratios for BMRN — quarterly report dated 2025-12-31
Total revenue: 874565000
Gross profit: 598856000
Operating income: -44603000
Net income: -46573000
Capital expenditures: 40722000
Operating cash flow: 99644000
Depreciation & amortization: 20438000
Net tangible assets: 5676963000
Owner earnings: -66857000
Return on net tangible assets (%): -1.1776895498526236
Buffett classification: The Gruesome
Stock price: 59.43
P/E ratio: 32.923076031137775
Shares outstanding: 193284438
Book value: 6086999000
P/B ratio: 1.8871194410151866
Market cap (USD): 11486894150.34
Debt to equity: 0.09953361254043248
Current ratio: 5.2086014932196445
Quick ratio: 3.4973630853021813
Interest coverage ratio: -16.055795536357092
COGS to revenue (%): 31.52527256407471
R&D to revenue (%): 22.000994780262186
SG&A to revenue (%): 51.01964976874217
Free cash flow (dilution-adjusted): 9641000
Buyback yield (%): 0
Retained earnings: 154206000
Inventory turnover: 0.21226623183150445
Receivables turnover: 0.9629503619191072
Capitalized R&D asset: 519994900
ROCI (R&D-adjusted, %): -1.4492164650739392
Rosenberg metric: -0.09082783446241312
FCF margin (%): 1.1023766100861572
Revenue growth (%): 12.682362430150503
Rule of 40 score: 13.78473904023666
Financial ratios for BOROLTD.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.6595015165501783
Shares outstanding: 119587629
Market cap (USD): 437631109.68614006
Buyback yield (%): 0
Retained earnings: 86979717.78979295
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOROLTD.NS — annual report dated 2023-03-31
Total revenue: 90325883.06942753
Gross profit: 35442241.16930573
Operating income: 4967965.8952496955
Net income: 6318258.221680878
Capital expenditures: 24047576.12667479
Operating cash flow: 14685712.545676006
Depreciation & amortization: 3357040.1948842877
Net tangible assets: 61935663.824604146
Owner earnings: -14372277.710109625
Return on net tangible assets (%): -23.20517263011911
Capex to operating income (%): 484.052761909432
Buffett classification: The Gruesome
Stock price: 3.3432399512789286
P/E ratio: 63.278537363286034
Shares outstanding: 119587629
Book value: 62116845.31059683
P/B ratio: 6.436420538621863
Market cap (USD): 399810138.9515226
Debt to equity: 0.35142661672738484
Current ratio: 1.393678961444172
Quick ratio: 0.8643779397792453
Effective tax rate (%): 21.412674773924465
Interest coverage ratio: 16.227818890745603
COGS to revenue (%): 60.761810496706005
SG&A to revenue (%): 19.98086506363816
Free cash flow (dilution-adjusted): -14783812.423873326
Buyback yield (%): 0
Retained earnings: 47886540.80389769
Inventory turnover: 3.1204964874957066
Receivables turnover: 14.44701708724019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.070634926963757
FCF margin (%): -16.367193900014225
Rule of 40 score: -16.367193900014225
Financial ratios for BOROLTD.NS — annual report dated 2024-03-31
Total revenue: 112993380.50125915
Gross profit: 48762405.56421633
Operating income: 10758508.214414198
Net income: 7898620.937762322
Capital expenditures: 20859167.765919175
Operating cash flow: 5759983.211416237
Depreciation & amortization: 6465127.7131550545
Net tangible assets: 69344381.82036215
Owner earnings: -6495419.115001798
Return on net tangible assets (%): -9.366900308994456
Capex to operating income (%): 193.8853170923099
Buffett classification: The Gruesome
Stock price: 4.285628598848368
P/E ratio: 64.88577777680543
Shares outstanding: 119587629
Book value: 69552836.0714714
P/B ratio: 7.36861631902721
Market cap (USD): 512508162.91086847
Debt to equity: 0.45285810664841847
Current ratio: 1.1830067432485623
Quick ratio: 0.5257518885931521
Effective tax rate (%): 25.010303503646643
Interest coverage ratio: 10.233750827002487
COGS to revenue (%): 56.844900694273015
SG&A to revenue (%): 19.09193487345951
Free cash flow (dilution-adjusted): -15381532.557860654
Buyback yield (%): 0
Retained earnings: 55062981.17280249
Inventory turnover: 2.118640977161075
Receivables turnover: 10.308593121782843
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.909568326524223
FCF margin (%): -13.612773146201471
Revenue growth (%): 25.09524032486746
Rule of 40 score: 11.48246717866599
Financial ratios for BOROLTD.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 90369242.71380793
Buffett classification: The Gruesome
Stock price: 4.806497849976111
Shares outstanding: 119587629
Book value: 90519290.49211659
P/B ratio: 6.350002066380542
Market cap (USD): 574797681.6722409
Debt to equity: 0.12606510056708156
Current ratio: 1.5397049415723392
Quick ratio: 0.5843204615780757
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOROLTD.NS — quarterly report dated 2025-03-31
Total revenue: 31585679.214402616
Gross profit: 20264987.140519053
Operating income: 1976151.5080664016
Net income: 1302852.4666822539
Capital expenditures: 0
Depreciation & amortization: 2367301.847089081
Net tangible assets: 94248468.55272387
Owner earnings: 3670154.313771335
Return on net tangible assets (%): 3.8941262071735427
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.898938032442526
P/E ratio: 89.46998352489624
Shares outstanding: 119587629
Book value: 94417827.91676408
P/B ratio: 4.938312659858811
Market cap (USD): 466264754.91772676
Debt to equity: 0.11522316409048919
Current ratio: 1.9631833175778897
Quick ratio: 0.6350257471869554
Effective tax rate (%): 34.19307600101563
Interest coverage ratio: 7.418264800105324
COGS to revenue (%): 35.841217777965305
Buyback yield (%): 0
Retained earnings: 62373930.32499415
Inventory turnover: 0.2908212664845528
Receivables turnover: 2.6682905825061503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9202847801413654
Rule of 40 score: 0
Financial ratios for BOROLTD.NS — annual report dated 2025-03-31
Total revenue: 129502595.27706335
Gross profit: 81977437.45616086
Operating income: 10405424.36287117
Net income: 8678325.929389758
Capital expenditures: 11316039.279869067
Operating cash flow: -2260042.085574
Depreciation & amortization: 9473754.968435818
Net tangible assets: 94248468.55272387
Owner earnings: 6836041.61795651
Return on net tangible assets (%): 7.253212410695391
Capex to operating income (%): 108.75134819342082
Buffett classification: The Gruesome
Stock price: 3.898938032442526
P/E ratio: 53.727499832506695
Shares outstanding: 119587629
Book value: 94417827.91676408
P/B ratio: 4.938312659858811
Market cap (USD): 466264754.91772676
Debt to equity: 0.11522316409048919
Current ratio: 1.9631833175778897
Quick ratio: 0.6350257471869554
Effective tax rate (%): 28.098794130466366
Interest coverage ratio: 6.963923857510581
COGS to revenue (%): 36.69822810826698
SG&A to revenue (%): 19.896571945029507
Free cash flow (dilution-adjusted): -13972387.187280804
Buyback yield (%): 0
Retained earnings: 62373930.32499415
Inventory turnover: 1.2208906043154752
Receivables turnover: 10.940102096342684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.111258146641187
FCF margin (%): -10.789271950409708
Revenue growth (%): 14.610780474543139
Rule of 40 score: 3.8215085241334315
Financial ratios for BOROLTD.NS — quarterly report dated 2025-06-30
Total revenue: 27227907.79311959
Gross profit: 18177088.696466185
Operating income: 1792323.894219518
Net income: 2037678.446056635
Capital expenditures: 0
Depreciation & amortization: 2576445.120524222
Owner earnings: 4614123.566580857
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.9884156330447
P/E ratio: 58.51820854578214
Shares outstanding: 119587629
Market cap (USD): 476965169.0223497
Effective tax rate (%): 25.830646500871
Interest coverage ratio: 9.226673091982411
COGS to revenue (%): 33.2409642541118
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -13.796668394251101
Rule of 40 score: -13.796668394251101
Financial ratios for BOROLTD.NS — quarterly report dated 2025-09-30
Total revenue: 38372040.58624577
Gross profit: 21929210.82299887
Operating income: 2958038.3314543404
Net income: 2560315.6708004507
Capital expenditures: 0
Depreciation & amortization: 2487023.675310034
Net tangible assets: 95807170.23675309
Owner earnings: 5047339.346110485
Return on net tangible assets (%): 5.268227141703271
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.903607666290868
P/E ratio: 79.11122222024399
Shares outstanding: 119587629
Book value: 95910428.41037205
P/B ratio: 4.867282871061229
Market cap (USD): 466823185.3579481
Debt to equity: 0.09412789436780723
Current ratio: 2.1212753418869013
Quick ratio: 0.894553874781376
Effective tax rate (%): 25.456908775799587
Interest coverage ratio: 17.757038440714673
COGS to revenue (%): 42.85106945587026
Buyback yield (%): 0
Inventory turnover: 0.45057797459117604
Receivables turnover: 2.0362451151893977
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.867765157994429
Revenue growth (%): 40.929082314368145
Rule of 40 score: 40.929082314368145
Financial ratios for BOROLTD.NS — quarterly report dated 2025-12-31
Total revenue: 37734967.13824218
Gross profit: 21715350.33975716
Operating income: 3472073.075637741
Net income: 2668085.1063829786
Capital expenditures: 0
Depreciation & amortization: 2418848.1675392673
Owner earnings: 5086933.273922246
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.137462403921132
P/E ratio: 43.786285564959364
Shares outstanding: 119587629
Market cap (USD): 375201689.9615685
Effective tax rate (%): 25.706061348627586
Interest coverage ratio: 23.184171377566198
COGS to revenue (%): 42.452976677565665
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.6602542848136812
Rule of 40 score: -1.6602542848136812
Financial ratios for BRN — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.95
Shares outstanding: 14395560
Market cap (USD): 42466902
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRN — annual report dated 2022-09-30
Total revenue: 28545000
Gross profit: 11737000
Operating income: 3693000
Net income: 6172000
Capital expenditures: 1315000
Operating cash flow: 7291000
Depreciation & amortization: 2778000
Net tangible assets: 19141000
Owner earnings: 7635000
Return on net tangible assets (%): 39.888198108771746
Capex to operating income (%): 35.60790685079881
Buffett classification: The Good
Stock price: 2.58
P/E ratio: 6.017586649384317
Shares outstanding: 14395560
Book value: 19161000
P/B ratio: 1.938340629403476
Market cap (USD): 37140544.800000004
Debt to equity: 0.008402484212723762
Current ratio: 2.2512602217990367
Quick ratio: 2.2512602217990367
Effective tax rate (%): 5.32290228562663
Interest coverage ratio: 3693
COGS to revenue (%): 58.88246628131021
SG&A to revenue (%): 28.18006656156945
Free cash flow (dilution-adjusted): -3586000
Buyback yield (%): 0
Retained earnings: 7720000
Receivables turnover: 6.545517083237789
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.055005656108598
FCF margin (%): -12.5626204238921
Rule of 40 score: -12.5626204238921
Financial ratios for BRN — annual report dated 2023-09-30
Total revenue: 25269000
Gross profit: 4709000
Operating income: -2247000
Net income: -811000
Capital expenditures: 233000
Operating cash flow: 1943000
Depreciation & amortization: 4457000
Net tangible assets: 18744000
Owner earnings: 3413000
Buffett classification: The Gruesome
Stock price: 2.64
Shares outstanding: 14395560
Book value: 18757000
P/B ratio: 2.026138422988751
Market cap (USD): 38004278.4
Debt to equity: 0.0025057311936876898
Current ratio: 1.3769324037587147
Quick ratio: 1.3769324037587147
Interest coverage ratio: -1123.5
COGS to revenue (%): 81.36451778859472
SG&A to revenue (%): 27.52780086271716
Free cash flow (dilution-adjusted): -9952000
Buyback yield (%): 0
Retained earnings: 6160000
Receivables turnover: 7.784658040665434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.795857474933213
FCF margin (%): -39.38422573113301
Revenue growth (%): -11.476615869679453
Rule of 40 score: -50.86084160081246
Financial ratios for BRN — annual report dated 2024-09-30
Total revenue: 18075000
Gross profit: 3276000
Operating income: -1854000
Net income: -5331000
Capital expenditures: 880000
Operating cash flow: 5334000
Depreciation & amortization: 4950000
Net tangible assets: 13040000
Owner earnings: -1261000
Return on net tangible assets (%): -9.670245398773005
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 14395560
Book value: 13062000
P/B ratio: 2.4907338539274226
Market cap (USD): 32533965.599999998
Debt to equity: 0.0005359056806002144
Current ratio: 1.1370967741935485
Quick ratio: 1.1370967741935485
COGS to revenue (%): 81.87551867219916
SG&A to revenue (%): 28.38174273858921
Free cash flow (dilution-adjusted): 1612000
Buyback yield (%): 0
Retained earnings: 595000
Receivables turnover: 8.253424657534246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.111300695629348
FCF margin (%): 8.918395573997234
Revenue growth (%): -28.469666389647397
Rule of 40 score: -19.551270815650163
Financial ratios for BRN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 14395560
Market cap (USD): 32533965.599999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 14395560
Market cap (USD): 21737295.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRN — quarterly report dated 2025-03-31
Total revenue: 3569000
Gross profit: 829000
Operating income: -1333000
Net income: -1207000
Capital expenditures: 0
Operating cash flow: -95000
Depreciation & amortization: 754000
Net tangible assets: 10135000
Owner earnings: -453000
Return on net tangible assets (%): -4.469659595461273
Buffett classification: The Gruesome
Stock price: 1.62
Shares outstanding: 14395560
Book value: 10155000
P/B ratio: 2.296485199409158
Market cap (USD): 23320807.200000003
Debt to equity: 0.01102904972919744
Current ratio: 0.988252267106348
Quick ratio: 0.988252267106348
Interest coverage ratio: -1333
COGS to revenue (%): 76.77220509946764
SG&A to revenue (%): 60.57719249089381
Free cash flow (dilution-adjusted): -267000
Buyback yield (%): 0
Retained earnings: -2529000
Receivables turnover: 1.3870967741935485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.827144686299616
FCF margin (%): -7.481087139254693
Rule of 40 score: -7.481087139254693
Financial ratios for BRN — quarterly report dated 2025-06-30
Total revenue: 3192000
Gross profit: 266000
Operating income: -1602000
Net income: -1550000
Capital expenditures: 0
Operating cash flow: -309000
Depreciation & amortization: 844000
Net tangible assets: 8566000
Owner earnings: -706000
Return on net tangible assets (%): -8.241886528134486
Buffett classification: The Gruesome
Stock price: 1.13
Shares outstanding: 14395560
Book value: 8583000
P/B ratio: 1.8952560643131773
Market cap (USD): 16266982.799999999
Debt to equity: 0.01246650355353606
Current ratio: 0.7571244714101857
Quick ratio: 0.7571244714101857
Interest coverage ratio: -400.5
COGS to revenue (%): 91.66666666666666
SG&A to revenue (%): 58.521303258145366
Free cash flow (dilution-adjusted): -640000
Buyback yield (%): 0
Retained earnings: -4079000
Receivables turnover: 1.3676092544987146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.745496233213233
FCF margin (%): -20.050125313283207
Revenue growth (%): -10.563182964415804
Rule of 40 score: -30.613308277699012
Financial ratios for BRN — annual report dated 2025-09-30
Total revenue: 13697000
Gross profit: 1585000
Operating income: -5352000
Net income: -7103000
Capital expenditures: 2722000
Operating cash flow: -1773000
Depreciation & amortization: 3146000
Net tangible assets: 7008000
Owner earnings: -6679000
Return on net tangible assets (%): -95.30536529680366
Buffett classification: The Gruesome
Stock price: 1.3
Shares outstanding: 14395560
Book value: 7022000
P/B ratio: 2.665085160922814
Market cap (USD): 18714228
Debt to equity: 0.013244090002848192
Current ratio: 1.106644096487516
Quick ratio: 1.106644096487516
Interest coverage ratio: -764.5714285714286
COGS to revenue (%): 88.42812294663065
SG&A to revenue (%): 50.646126889099804
Free cash flow (dilution-adjusted): -5219000
Buyback yield (%): 0
Retained earnings: -6508000
Receivables turnover: 7.1301405517959395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.271167474822825
FCF margin (%): -38.1032342848799
Revenue growth (%): -24.22130013831259
Rule of 40 score: -62.32453442319249
Financial ratios for BRN — quarterly report dated 2025-09-30
Total revenue: 3002000
Gross profit: -44000
Operating income: -1788000
Net income: -2429000
Capital expenditures: 2440000
Operating cash flow: -610000
Depreciation & amortization: 644000
Net tangible assets: 7008000
Owner earnings: -4225000
Return on net tangible assets (%): -60.28824200913242
Buffett classification: The Gruesome
Stock price: 1.3
Shares outstanding: 14395560
Book value: 7022000
P/B ratio: 2.665085160922814
Market cap (USD): 18714228
Debt to equity: 0.013244090002848192
Current ratio: 1.106644096487516
Quick ratio: 1.106644096487516
Interest coverage ratio: -894
COGS to revenue (%): 101.46568954030646
SG&A to revenue (%): 58.094603597601605
Free cash flow (dilution-adjusted): -955000
Buyback yield (%): 0
Retained earnings: -6508000
Receivables turnover: 1.5627277459656428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.115255501678478
FCF margin (%): -31.812125249833446
Revenue growth (%): -5.952380952380952
Rule of 40 score: -37.7645062022144
Financial ratios for BRN — quarterly report dated 2025-12-31
Total revenue: 2746000
Gross profit: 83000
Operating income: -1533000
Net income: -1412000
Capital expenditures: 0
Operating cash flow: -1767000
Depreciation & amortization: 592000
Net tangible assets: 8158000
Owner earnings: -820000
Return on net tangible assets (%): -10.051483206668301
Buffett classification: The Gruesome
Stock price: 1.11
Shares outstanding: 14395560
Book value: 8186000
P/B ratio: 1.9519999511360862
Market cap (USD): 15979071.600000001
Debt to equity: 0.01001710236989983
Current ratio: 1.456385903524119
Quick ratio: 1.456385903524119
COGS to revenue (%): 96.97742170429716
SG&A to revenue (%): 58.84923525127458
Free cash flow (dilution-adjusted): -1889000
Buyback yield (%): 0
Retained earnings: -7934000
Receivables turnover: 1.7045313469894476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.777052559257987
FCF margin (%): -68.79096868171887
Revenue growth (%): -8.527648234510327
Rule of 40 score: -77.31861691622919
Financial ratios for CAMBI.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8745724059293045
Shares outstanding: 160025696
Market cap (USD): 139954057.96123147
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAMBI.OL — annual report dated 2022-12-31
Total revenue: 44574898.7854251
Gross profit: 22429149.797570847
Operating income: -1589068.825910931
Net income: -1174089.0688259108
Capital expenditures: 283400.8097165992
Operating cash flow: 5951417.004048582
Depreciation & amortization: 1852226.7206477732
Net tangible assets: 35384615.384615384
Owner earnings: 394736.84210526326
Buffett classification: The Gruesome
Stock price: 0.4331983805668016
Shares outstanding: 160025696
Book value: 40688259.10931174
P/B ratio: 1.7037561663681595
Market cap (USD): 69322872.3562753
Debt to equity: 0.0027363184079601988
Current ratio: 2.725028702640643
Quick ratio: 2.47646383467279
Interest coverage ratio: -4.361111111111111
COGS to revenue (%): 49.68210717529519
SG&A to revenue (%): 1.2261580381471389
Free cash flow (dilution-adjusted): 718623.4817813764
Buyback yield (%): 0
Inventory turnover: 5.053117782909931
Receivables turnover: 5.5465994962216625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8948151823368886
FCF margin (%): 1.612170753860127
Rule of 40 score: 1.612170753860127
Financial ratios for CAMBI.OL — annual report dated 2023-12-31
Total revenue: 95933202.35756385
Gross profit: 52180746.56188605
Operating income: 22111984.28290766
Net income: 18084479.371316306
Capital expenditures: 1817288.8015717093
Operating cash flow: 20717092.337917484
Depreciation & amortization: 2367387.0333988215
Net tangible assets: 30225933.202357564
Owner earnings: 18634577.60314342
Return on net tangible assets (%): 61.65095872603186
Capex to operating income (%): 8.21856952465571
Buffett classification: The Great
Stock price: 1.5333988212180747
P/E ratio: 13.568718710266161
Shares outstanding: 160025696
Book value: 33271119.84282908
P/B ratio: 7.375261631414231
Market cap (USD): 245383213.61100197
Debt to equity: 0.000590493061706525
Current ratio: 1.7312418300653594
Quick ratio: 1.5458823529411763
Effective tax rate (%): 20.052424639580604
Interest coverage ratio: 15.741258741258738
COGS to revenue (%): 45.60720868318657
SG&A to revenue (%): 0.6450952283432316
Free cash flow (dilution-adjusted): 18889980.353634577
Buyback yield (%): 0
Inventory turnover: 6.282087447108604
Receivables turnover: 10.236897274633124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 64.05805350028457
FCF margin (%): 19.690763874667212
Revenue growth (%): 115.21799257328134
Rule of 40 score: 134.90875644794855
Financial ratios for CAMBI.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2671755725190839
Shares outstanding: 160025696
Market cap (USD): 202780652.94656485
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAMBI.OL — annual report dated 2024-12-31
Total revenue: 91209179.17034422
Gross profit: 50494263.01853486
Operating income: 17616946.160635483
Net income: 13212709.620476611
Capital expenditures: 1844660.1941747572
Operating cash flow: -1456310.6796116505
Depreciation & amortization: 2303618.711385702
Net tangible assets: 40794351.279788174
Owner earnings: 13671668.137687555
Return on net tangible assets (%): 33.513630463003025
Capex to operating income (%): 10.470941883767534
Buffett classification: The Great
Stock price: 1.2037037037037037
P/E ratio: 14.578654075954379
Shares outstanding: 160025696
Book value: 42021182.70079435
P/B ratio: 4.583962434720375
Market cap (USD): 192623522.96296296
Debt to equity: 0
Current ratio: 2.5926829268292684
Quick ratio: 2.042508710801394
Effective tax rate (%): 21.81913774973712
Interest coverage ratio: 15.472868217054266
COGS to revenue (%): 44.63905554480356
SG&A to revenue (%): 0.7741436036384749
Free cash flow (dilution-adjusted): -3300970.8737864075
Buyback yield (%): 0
Inventory turnover: 2.9214692843571886
Receivables turnover: 6.0362149532710285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.27420901246406
FCF margin (%): -3.6191213470098704
Revenue growth (%): -4.924283846600028
Rule of 40 score: -8.5434051936099
Financial ratios for CAMBI.OL — quarterly report dated 2024-12-31
Total revenue: 20644307.149161518
Gross profit: 11985878.199470432
Operating income: 2780229.4792586053
Net income: 2374227.7140335394
Capital expenditures: 229479.2586054722
Operating cash flow: -1429832.3036187114
Depreciation & amortization: 626654.8984995587
Net tangible assets: 40794351.279788174
Owner earnings: 2771403.353927626
Return on net tangible assets (%): 6.793595845954132
Capex to operating income (%): 8.253968253968253
Buffett classification: The Great
Stock price: 1.2037037037037037
P/E ratio: 20.28275571719675
Shares outstanding: 160025696
Book value: 42021182.70079435
P/B ratio: 4.583962434720375
Market cap (USD): 192623522.96296296
Debt to equity: 0
Current ratio: 2.5926829268292684
Quick ratio: 2.042508710801394
Effective tax rate (%): 22.22222222222222
COGS to revenue (%): 41.94100042753313
Free cash flow (dilution-adjusted): -1659311.5622241835
Buyback yield (%): 0
Inventory turnover: 0.6212792906903103
Receivables turnover: 1.3662383177570094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.0402684563758395
FCF margin (%): -8.037622915775973
Rule of 40 score: -8.037622915775973
Financial ratios for CAMBI.OL — quarterly report dated 2025-03-31
Total revenue: 21479007.633587785
Gross profit: 10047709.923664121
Operating income: 639312.9770992366
Net income: 410305.34351145034
Capital expenditures: 190839.69465648854
Operating cash flow: -5057251.908396946
Depreciation & amortization: 667938.9312977099
Net tangible assets: 43282442.7480916
Owner earnings: 887404.5801526718
Return on net tangible assets (%): 2.0502645502645507
Capex to operating income (%): 29.85074626865672
Buffett classification: The Good
Stock price: 1.5181297709923665
P/E ratio: 148.0237688
Shares outstanding: 160025696
Book value: 44103053.4351145
P/B ratio: 5.508456995586327
Market cap (USD): 242939773.22137406
Debt to equity: 0
Current ratio: 2.6795497185741093
Quick ratio: 2.101313320825516
Effective tax rate (%): 20
COGS to revenue (%): 53.22079075966237
Free cash flow (dilution-adjusted): -5248091.603053435
Buyback yield (%): 0
Inventory turnover: 0.7774172615184946
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3199369582348306
FCF margin (%): -24.433585073300755
Revenue growth (%): 4.043247750555627
Rule of 40 score: -20.39033732274513
Financial ratios for CAMBI.OL — quarterly report dated 2025-06-30
Total revenue: 33942403.177755706
Gross profit: 16772591.857000992
Operating income: 7010923.535253227
Net income: 8937437.934458788
Capital expenditures: 367428.0039721946
Operating cash flow: 10675273.08838133
Depreciation & amortization: 456802.38331678254
Net tangible assets: 53932472.69116186
Owner earnings: 9026812.313803377
Return on net tangible assets (%): 16.737249125391273
Capex to operating income (%): 5.240793201133145
Buffett classification: The Great
Stock price: 1.8063555114200596
P/E ratio: 24.659956771401113
Shares outstanding: 160025696
Book value: 54597815.292949356
P/B ratio: 5.294411440960349
Market cap (USD): 289063297.93843096
Debt to equity: 0
Current ratio: 3.041095890410959
Quick ratio: 2.333333333333333
Effective tax rate (%): 14.719848053181389
COGS to revenue (%): 50.58513750731423
Free cash flow (dilution-adjusted): 10278053.624627607
Buyback yield (%): 0
Inventory turnover: 0.9295698924731184
Receivables turnover: 1.1913558731265248
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.85956660507307
FCF margin (%): 30.28086600351083
Revenue growth (%): 58.02593749572627
Rule of 40 score: 88.3068034992371
Financial ratios for CAMBI.OL — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8517034068136273
P/E ratio: 25.279035979790315
Shares outstanding: 160025696
Market cap (USD): 296320126.4609219
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAMBI.OL — annual report dated 2025-12-31
Total revenue: 106298507.46268655
Gross profit: 52746268.656716414
Operating income: 14149253.731343282
Net income: 13651741.293532338
Capital expenditures: 686567.1641791044
Operating cash flow: 27044776.119402982
Depreciation & amortization: 1870646.766169154
Net tangible assets: 44258706.467661686
Owner earnings: 14835820.895522386
Return on net tangible assets (%): 33.52068345323741
Capex to operating income (%): 4.852320675105485
Buffett classification: The Great
Stock price: 1.6105577689243031
P/E ratio: 18.878956345475245
Shares outstanding: 160025696
Book value: 46676616.91542289
P/B ratio: 5.521621851629085
Market cap (USD): 257730627.92031878
Debt to equity: 0
Current ratio: 2.3951900237529693
Quick ratio: 2.048693586698337
Effective tax rate (%): 21.453089244851263
Interest coverage ratio: 19.47945205479452
COGS to revenue (%): 50.37910699241787
SG&A to revenue (%): 0.7862959842740803
Free cash flow (dilution-adjusted): 26278606.965174127
Buyback yield (%): 0
Inventory turnover: 4.611825192802057
Receivables turnover: 5.575678496868476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.313841598815692
FCF margin (%): 24.721520172236264
Revenue growth (%): 16.543651011441714
Rule of 40 score: 41.26517118367798
Financial ratios for CAMBI.OL — quarterly report dated 2025-12-31
Total revenue: 24348258.70646766
Gross profit: 12636815.92039801
Operating income: 2427860.6965174126
Net income: -19900.49751243781
Capital expenditures: 49751.24378109453
Operating cash flow: 13522388.059701491
Depreciation & amortization: 368159.20398009947
Net tangible assets: 44258706.467661686
Owner earnings: 298507.4626865671
Capex to operating income (%): 2.0491803278688527
Buffett classification: The Great
Stock price: 1.6105577689243031
P/E ratio: 27.630249993093216
Shares outstanding: 160025696
Book value: 46676616.91542289
P/B ratio: 5.521621851629085
Market cap (USD): 257730627.92031878
Debt to equity: 0
Current ratio: 2.3951900237529693
Quick ratio: 2.048693586698337
Effective tax rate (%): 100.86206896551724
COGS to revenue (%): 48.09971393543114
Free cash flow (dilution-adjusted): 13482587.064676616
Buyback yield (%): 0
Inventory turnover: 1.0085689802913453
Receivables turnover: 1.2771398747390397
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.515173945225758
FCF margin (%): 55.37392725786678
Rule of 40 score: 55.37392725786678
Financial ratios for CAN.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -330334.9650349651
Net income: -863006.9930069931
Capital expenditures: 379383.9160839161
Operating cash flow: -210460.13986013987
Depreciation & amortization: 0
Net tangible assets: 2849065.034965035
Owner earnings: -1242390.9090909092
Return on net tangible assets (%): -43.60696908788382
Buffett classification: The Gruesome
Stock price: 0.18181818181818182
Shares outstanding: 54868876
Book value: 2849065.034965035
P/B ratio: 3.5015554753209432
Market cap (USD): 9976159.272727273
Debt to equity: 0
Current ratio: 2.5746223602903826
Quick ratio: 2.5746223602903826
Interest coverage ratio: -105.11326212728083
Free cash flow (dilution-adjusted): -589844.055944056
Buyback yield (%): 0
Retained earnings: -1054020.2797202799
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.498545700353176
Rule of 40 score: 0
Financial ratios for CAN.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -243662.93706293707
Net income: -768435.6643356644
Capital expenditures: 0
Operating cash flow: -193147.55244755244
Net tangible assets: 2849065.034965035
Owner earnings: -768435.6643356644
Return on net tangible assets (%): -26.971503103827704
Buffett classification: The Gruesome
Stock price: 0.18181818181818182
Shares outstanding: 54868876
Book value: 2849065.034965035
P/B ratio: 3.5015554753209432
Market cap (USD): 9976159.272727273
Debt to equity: 0
Current ratio: 2.5746223602903826
Quick ratio: 2.5746223602903826
Interest coverage ratio: -78.51239296980623
Free cash flow (dilution-adjusted): -572531.4685314685
Buyback yield (%): 0
Retained earnings: -1054020.2797202799
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.481601143868927
Rule of 40 score: 0
Financial ratios for CAN.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -471455.24475524476
Net income: -440534.9650349651
Capital expenditures: 71839.86013986015
Operating cash flow: -441059.4405594406
Net tangible assets: 2692486.713286713
Owner earnings: -512374.8251748252
Return on net tangible assets (%): -19.029799576963196
Buffett classification: The Gruesome
Stock price: 0.13986013986013987
Shares outstanding: 54868876
Book value: 2692486.7132867137
P/B ratio: 2.850141704863261
Market cap (USD): 7673968.671328672
Debt to equity: 0
Current ratio: 2.7451815766916465
Quick ratio: 2.7451815766916465
Interest coverage ratio: -690.0522006141248
Free cash flow (dilution-adjusted): -773079.7202797204
Buyback yield (%): 0
Retained earnings: -1494555.2447552448
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.510030501867927
Rule of 40 score: 0
Financial ratios for CAN.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -170895.62043795618
Net income: -133380.2919708029
Capital expenditures: 156115.32846715327
Operating cash flow: -158411.67883211677
Net tangible assets: 2677025.5474452553
Owner earnings: -289495.6204379562
Return on net tangible assets (%): -10.814077613649532
Buffett classification: The Gruesome
Stock price: 0.0948905109489051
Shares outstanding: 54868876
Book value: 2677025.5474452553
P/B ratio: 1.944895775761583
Market cap (USD): 5206535.678832117
Debt to equity: 0
Current ratio: 2.3694560260979354
Quick ratio: 2.3694560260979354
Interest coverage ratio: -257.8491189427313
Free cash flow (dilution-adjusted): -314527.0072992701
Buyback yield (%): 0
Retained earnings: -1693390.510948905
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.383787431578517
Rule of 40 score: 0
Financial ratios for CAN.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -1773.381294964029
Operating income: -207169.06474820146
Net income: -158997.12230215827
Capital expenditures: 171638.1294964029
Operating cash flow: -283201.43884892086
Net tangible assets: 2493991.366906475
Owner earnings: -330635.2517985612
Return on net tangible assets (%): -13.25727330839474
Buffett classification: The Gruesome
Stock price: 0.1798561151079137
Shares outstanding: 54868876
Book value: 2493991.3669064753
P/B ratio: 3.95691140259986
Market cap (USD): 9868502.877697842
Debt to equity: 0.014822675968255213
Current ratio: 1.9216635204853059
Quick ratio: 1.9216635204853059
Interest coverage ratio: -166.64641203703707
Free cash flow (dilution-adjusted): -469320.86330935254
Buyback yield (%): 0
Retained earnings: -1828022.3021582735
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.199143825621737
Rule of 40 score: 0
Financial ratios for CCD — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.56
Shares outstanding: 28582859
Market cap (USD): 587663581.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCD — annual report dated 2022-10-31
Total revenue: -232158399
Net income: -232782492
Capital expenditures: 0
Operating cash flow: 64124779
Net tangible assets: 526612762
Owner earnings: -232782492
Return on net tangible assets (%): -44.203731621680674
Buffett classification: The Gruesome
Stock price: 15.07
Shares outstanding: 28582859
Book value: 526612762
P/B ratio: 0.8179514744270479
Market cap (USD): 430743685.13
Debt to equity: 0.43675356276306876
Free cash flow (dilution-adjusted): 64124779
Buyback yield (%): 0.001494856505686598
Retained earnings: -25331079
Receivables turnover: -74.66847431918741
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCD — annual report dated 2023-10-31
Total revenue: -16532569
Net income: -17071604
Capital expenditures: 0
Operating cash flow: 54517111
Net tangible assets: 459365026
Owner earnings: -17071604
Return on net tangible assets (%): -3.716348227172175
Buffett classification: The Gruesome
Stock price: 13.11
Shares outstanding: 28582859
Book value: 459365026
P/B ratio: 0.815737507822374
Market cap (USD): 374721281.49
Debt to equity: 0.4571527828938375
Free cash flow (dilution-adjusted): 54517111
Buyback yield (%): 0
Retained earnings: -103734412
Receivables turnover: -2.2844550203634495
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCD — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 516997483
Buffett classification: The Gruesome
Stock price: 20.32
Shares outstanding: 28582859
Book value: 516997483
P/B ratio: 1.1234168714125057
Market cap (USD): 580803694.88
Debt to equity: 0.40667509400621205
Buyback yield (%): 0
Retained earnings: -29364398
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCD — annual report dated 2024-10-31
Total revenue: 115867658
Net income: 115378765
Capital expenditures: 0
Operating cash flow: 56246270
Net tangible assets: 516997483
Owner earnings: 115378765
Return on net tangible assets (%): 22.31708447215013
Buffett classification: The Gruesome
Stock price: 20.32
P/E ratio: 5.033887257156896
Shares outstanding: 28582859
Book value: 516997483
P/B ratio: 1.1234168714125057
Market cap (USD): 580803694.88
Debt to equity: 0.40667509400621205
COGS to revenue (%): 0
SG&A to revenue (%): 0.3445448081810716
Free cash flow (dilution-adjusted): 56246270
Buyback yield (%): 0.03814800111520943
Retained earnings: -29364398
Receivables turnover: 27.17778080619273
Capitalized R&D asset: 0
FCF margin (%): 48.543546120523125
Rule of 40 score: 48.543546120523125
Financial ratios for CCD — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 474975485
Buffett classification: The Gruesome
Stock price: 18.98
Shares outstanding: 28582859
Book value: 474975485
P/B ratio: 1.14216981918551
Market cap (USD): 542502663.82
Debt to equity: 0.39002012914413886
Buyback yield (%): 0
Retained earnings: -75299786
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLPR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.95
Shares outstanding: 16157566
Market cap (USD): 112295083.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0